Evidence map›Paper›PMID 28877928›Full record

ArticleClinical and vaccine immunology : CVI2017

Anthrax Vaccine Precipitated Induces Edema Toxin-Neutralizing, Edema Factor-Specific Antibodies in Human Recipients.

Eric K Dumas, Timothy Gross, Jason Larabee, Lance Pate, Hannah Cuthbertson, Sue Charlton, Bassam Hallis, Renata J M Engler, Limone C Collins, Christina E Spooner and 4 more

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical and vaccine immunology : CVI, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 25 citations in OpenAlex.

  1. Human anthrax vaccines: Current status and future prospects.Human vaccines & immunotherapeutics · 2025
    Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. TheMicrobiology spectrum · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 2 countries.

Eric K DumasArthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation (OMRF), Oklahoma City, Oklahoma, USA.
Timothy GrossArthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation (OMRF), Oklahoma City, Oklahoma, USA.
Jason LarabeeDepartment of Microbiology and Immunology, University of Oklahoma Health Sciences Center (OUHSC), Oklahoma City, Oklahoma, USA.
Lance PateArthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation (OMRF), Oklahoma City, Oklahoma, USA.
Hannah CuthbertsonPublic Health England, National Infection Service, Porton Down, Salisbury, United Kingdom.
Sue CharltonPublic Health England, National Infection Service, Porton Down, Salisbury, United Kingdom.
Bassam HallisPublic Health England, National Infection Service, Porton Down, Salisbury, United Kingdom.
Renata J M EnglerWalter Reed National Military Medical Center, Bethesda, Maryland, USA.
Limone C CollinsWalter Reed National Military Medical Center, Bethesda, Maryland, USA.
Christina E SpoonerWalter Reed National Military Medical Center, Bethesda, Maryland, USA.
Hua ChenArthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation (OMRF), Oklahoma City, Oklahoma, USA.
Jimmy BallardDepartment of Microbiology and Immunology, University of Oklahoma Health Sciences Center (OUHSC), Oklahoma City, Oklahoma, USA.
Judith A JamesArthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation (OMRF), Oklahoma City, Oklahoma, USA.
A Darise FarrisArthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation (OMRF), Oklahoma City, Oklahoma, USA darise-farris@omrf.org.ORCID http://orcid.org/0000-0003-3009-2017
Oklahoma Medical Research Foundation · USPublic Health England · GBWalter Reed National Military Medical Center · USUniversity of Oklahoma Health Sciences Center · US

Funding

Tracking and Evaluation CoreU54GM104938 · NIGMS · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI Robert Hal Scofield · 2013 to 2026
$68.2M
Translation of immunologic technologies from basic research into pre-clinical nonU19AI062629 · NIAID · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI COGGESHALL, KENNETH MARK · 2004 to 2023
$56.2M
Science in a Culture of MentoringP30GM103510 · NIGMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI JAMES, JUDITH A · 2012 to 2016
$3.9M
NIAID NIH HHS U19 AI062629NIGMS NIH HHS P30 GM103510NIGMS NIH HHS U54 GM104938
6 · The paper itself

Abstract

Edema toxin (ET), composed of edema factor (EF) and protective antigen (PA), is a virulence factor of

Indexed as

AdultAnimalsAnthraxAnthrax VaccinesAntibodies, BacterialAntibodies, NeutralizingAntigens, BacterialBacillus anthracisBacterial ToxinsFemaleHumansImmunoglobulin GMaleMiceMiddle AgedNeutralization Testsanthrax toxinAnthrax VaccinesAntibodies, BacterialAntibodies, NeutralizingAntigens, BacterialBacterial ToxinsImmunoglobulin GantibodyBacillus anthracisedema toxinvaccine

Identifiers

PMID28877928
PMCPMC5674197
OpenAlexW2753049721

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.